Noopept vs GPE

Head-to-head comparison of Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) and GPE (Glycyl-L-prolyl-L-glutamic acid) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyNoopeptGPE
CategoryCognitive EnhancementCognitive Enhancement
Full NameN-phenylacetyl-L-prolylglycine ethyl esterGlycyl-L-prolyl-L-glutamic acid
Molecular Weight318.37 Da301.30 Da
Half-Life20-30 minutesminutes
Amino AcidsN/A3
Typical Dose10-30 mg/day0.1-10 mg/kg preclinical
RouteOralIntranasal/Intracerebroventricular
Purity≥98%≥98%
Studies Count6025
Research StatusClinicalPre-clinical

Noopept Benefits

  • memory recall
  • learning efficiency
  • attention support
  • neurotrophic signaling

GPE Benefits

  • memory consolidation
  • neuroprotection
  • synaptic plasticity
  • learning support

Noopept Dosing

oral research use|10-30 mg per day in human studies|divided or single daily dosing

GPE Dosing

intranasal or ICV research doses|0.1-10 mg/kg preclinical range|repeat daily or intermittent protocols

Noopept Side Effects

  • headache
  • irritability
  • sleep disturbance

GPE Side Effects

  • limited human safety data
  • short half-life
  • local irritation with nasal delivery

Research Overview

Noopept

Noopept has been reported to increase NGF/BDNF-related signaling and improve performance in tasks involving learning and recall. Evidence includes preclinical studies and small human studies, but the overall literature is still modest compared with mainstream cognitive drugs.

GPE

Preclinical studies suggest GPE can reduce neuronal damage and support plasticity-related pathways in the brain. Research interest centers on hippocampal function, which links it to learning and memory paradigms.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Noopept stacks with:

gpedavunetidedesmopressin

GPE stacks with:

davunetidenoopeptarginine-vasopressin
peptide-derivednootropicmemorytripeptideneuroprotection